• 목록
• 답변
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD must make a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breastfeeding. There aren't enough data regarding how does adhd medication work for adults exposure over time may affect the pregnant fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological conditions like impaired vision or hearing seizures, febrile seizures or IQ impairment. The authors acknowledge that further high-quality studies are needed.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication should consider the benefits of taking it against the potential dangers for the foetus. Doctors don't have the information needed to make unequivocal recommendations however they can provide information on risks and benefits that aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not have an increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a large sample-based case control study to examine the prevalence of structural defects that were major in infants born to mothers who used stimulants during pregnancy. Clinical geneticists and pediatric cardiologists looked over the cases to ensure an accurate case classification and to limit the possibility of bias.

However, the study had its limitations. The researchers were not able in the beginning, to separate the effects triggered by the medication from the disorder. This limitation makes it difficult for researchers to determine whether the few associations observed between the groups exposed were due to the use of medications, or if they were affected by the presence of comorbidities. Additionally, the researchers did not study long-term offspring outcomes.

The study did reveal that infants whose mothers had taken adhd medication for adults uk medication during pregnancy were at a more risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or cut back on their medications prior to or during pregnancy. This was due to central nervous system-related disorders and the increased risk of admission was not found to be influenced by which stimulant medication was used during pregnancy.

Women who were taking stimulant liquid adhd medication uk (visit my website) medications during pregnancy also had a higher chance of having a caesarean section or a baby that scored low on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication used during pregnancy.

The researchers suggest that the small risk associated with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefits for both mother and child from continued treatment for the woman's condition. Physicians should discuss the issue with their patients and, when they are able, assist them in developing strategies for improving their coping skills that can lessen the effects of her disorder on her daily life and relationships.

Interactions with Medication

More and more doctors are confronted with the dilemma of whether to continue treatment or stop it during pregnancy as more women are diagnosed with ADHD. Often, these decisions are made without solid and reliable evidence in either case, which means that doctors must weigh what they know, the experiences of other doctors, and what the research suggests about the subject and their best adhd medication for adults judgment for each patient.

Particularly, the subject of potential risks to the baby can be tricky. Many of the studies on this issue are based on observational evidence instead of controlled research and their findings are often contradictory. Most studies restrict their analysis to live births, which may underestimate the severity of teratogenic effects leading to abortions or terminations of pregnancy. The study that is discussed in this journal club addresses these shortcomings by looking at data from both live and deceased births.

The conclusion The conclusion: While some studies have shown that there is a positive correlation between ADHD medications and the possibility of certain birth defects, others have found no such relationship, and most studies have a neutral or slightly negative effect. In all cases, a careful evaluation of the potential risks and benefits is required.

For women suffering from adhd medication for women who suffer from ADHD, the decision to discontinue medication can be difficult, if not impossible. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of being isolated. A loss of medication may also affect the ability to drive safely and complete work-related tasks, which are essential aspects of everyday life for those suffering from ADHD.

She suggests that women who are unsure whether to take the medication or stop it due to their pregnancy, educate their family members, coworkers and their friends about the condition, its effects on daily functioning, and the benefits of continuing the current treatment plan. It can also help women feel confident about her decision. It is important to remember that some medications are able to be absorbed through the placenta therefore, if a patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the medication could be transferred to the child.

Birth Defects Risk

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about what impact the drugs could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this topic. With two massive data sets researchers were able examine more than 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. Researchers discovered that, while the risk overall is low, first-trimester ADHD exposure to medication was associated with slightly higher risk of specific heart defects such as ventriculoseptal defect.

The authors of the study found no association between early use of medication and other congenital abnormalities, such as facial clefting or club foot. The results are in line with previous studies showing a small but significant increase in the risk of cardiac malformations among women who started taking ADHD medications prior to the birth of their child. This risk increased in the latter half of pregnancy, when many women begin to discontinue their ADHD medication.

Women who used ADHD medications in the first trimester of their pregnancy were also more likely to have caesarean section, low Apgar score following delivery, and a baby who required breathing assistance at birth. However the authors of the study were not able to eliminate selection bias by restricting the study to women who didn't have any other medical conditions that could be a contributing factor to these findings.

Researchers hope their research will help doctors when they encounter pregnant women. The researchers advise that while discussing benefits and risks are important, the choice on whether to continue or stop medication should be made based on the severity of each woman's ADHD symptoms and her needs.

The authors warn that, while stopping the medication is an option to think about, it isn't advised because of the high incidence of depression and other mental problems among women who are pregnant or who have recently given birth. Additionally, the research suggests that women who decide to stop taking their medication are more likely to have a difficult time getting used to life without them after the baby's arrival.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women who suffer from ADHD who have to deal with their symptoms while attending doctor appointments and getting ready for the arrival of a child and adjusting to new household routines may face a lot of challenges. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant medicines are absorbed by breast milk in small quantities, so the risk to the breastfeeding infant is minimal. However, the rate of exposure to medication by the infant can differ based on the dosage, frequency it is taken and at what time the medication is administered. In addition, various medications are introduced into the baby's system through the gastrointestinal tract or breast milk. The effect on the health of a newborn is not completely understood.

Some doctors may stop taking stimulant medication during a woman's pregnancy due to the absence of research. This is a difficult decision for the mother, who must weigh the benefits of her medication against the risks to the embryo. In the meantime, until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and whether they are planning or taking to take medication during the perinatal time.

A increasing number of studies have shown that the majority of women are able to safely continue taking their ADHD medication during pregnancy and while breastfeeding. In response, a growing number of patients are choosing to continue their medication. They have found through consultation with their doctors that the benefits of keeping their current medication outweigh any risk.

Women with ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should discuss the medication they are taking with their physician as well as the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also needed to help pregnant women with ADHD be aware of the symptoms and the underlying disorder. They should also be educated about treatment options and strengthen strategies for coping. This should include an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counseling should include discussion of a treatment plan for the mother as well as the child, and monitoring for indicators of deterioration, and, if necessary modifications to the medication regimen.